Table of Contents Author Guidelines Submit a Manuscript
Clinical and Developmental Immunology
Volume 2008 (2008), Article ID 481560, 7 pages
http://dx.doi.org/10.1155/2008/481560
Research Article

Do the Changes in the Serum Levels of IL-2, IL-4, TNF , and IL-6 Reflect the Inflammatory Activity in the Patients with Post-ERCP Pancreatitis?

1Department of Gastroenterology, Gulhane Military Medical Academy, School of Medicine, Etlik, 06010 Ankara, Turkey
2Department of Immunology, Gulhane Military Medical Academy, School of Medicine, Etlik, 06010 Ankara, Turkey
3Department of Internal Medicine, Gulhane Military Medical Academy, Haydarpasa Training Hospital, Uskudar, 34668 Istanbul, Turkey

Received 11 December 2007; Revised 25 March 2008; Accepted 2 June 2008

Academic Editor: Shyam Mohapatra

Copyright © 2008 Guldem Kilciler et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. Skude, L. Wehlin, T. Maruyana, and J. Ariyama, “Hyperamylasaemia after duodenoscopy and retrograde cholangiopancreatography,” Gut, vol. 17, no. 2, pp. 127–132, 1976. View at Publisher · View at Google Scholar
  2. C.-C. Chen, S.-S. Wang, R.-H. Lu, C.-C. Lu, F.-Y. Chang, and S.-D. Lee, “Early changes of serum proinflammatory and anti-inflammatory cytokines after endoscopic retrograde cholangiopancreatography,” Pancreas, vol. 26, no. 4, pp. 375–380, 2003. View at Publisher · View at Google Scholar
  3. K. Gottlieb, S. Sherman, J. Pezzi, E. Esber, and G. A. Lehman, “Early recognition of post-ERCP pancreatitis by clinical assessment and serum pancreatic enzymes,” The American Journal of Gastroenterology, vol. 91, no. 8, pp. 1553–1557, 1996. View at Google Scholar
  4. S. Sultan and J. Baillie, “What are the predictors of post-ERCP pancreatitis, and how useful are they?” Journal of the Pancreas, vol. 3, no. 6, pp. 188–194, 2002. View at Google Scholar
  5. J.-L. Frossard, A. Hadengue, and C. M. Pastor, “New serum markers for the detection of severe acute pancreatitis in humans,” American Journal of Respiratory and Critical Care Medicine, vol. 164, no. 1, pp. 162–170, 2001. View at Google Scholar
  6. C. A. Dinarello, “Interleukin-1, interleukin-1 receptors and interleukin-1 receptor antagonist,” International Reviews of Immunology, vol. 16, no. 5-6, pp. 457–499, 1998. View at Publisher · View at Google Scholar
  7. T. R. Mosmann, H. Cherwinski, M. W. Bond, M. A. Giedlin, and R. L. Coffman, “Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins,” The Journal of Immunology, vol. 136, no. 7, pp. 2348–2357, 1986. View at Google Scholar
  8. A. Kelso, “Th1 and Th2 subsets: paradigms lost?” Immunology Today, vol. 16, no. 8, pp. 374–379, 1995. View at Publisher · View at Google Scholar
  9. A. K. Abbas and A. H. Lichtman, “Cytokines,” in Cellular and Molecular Immunology, A. K. Abbas and A. H. Lichtman, Eds., chapter 11, pp. 243–274, Saunders, Philadelphia, Pa, USA, 5th edition, 2003. View at Google Scholar
  10. A. K. Abbas and A. H. Lichtman, “Immunity to microbes,” in Cellular and Molecular Immunology, A. K. Abbas and A. H. Lichtman, Eds., chapter 15, pp. 345–366, Saunders, Philadelphia, Pa, USA, 5th edition, 2003. View at Google Scholar
  11. A. Doria, L. Iaccarino, S. Arienti et al., “Th2 immune deviation induced by pregnancy: the two faces of autoimmune rheumatic diseases,” Reproductive Toxicology, vol. 22, no. 2, pp. 234–241, 2006. View at Publisher · View at Google Scholar
  12. P. A. Testoni, “Why the incidence of post-ERCP pancreatitis varies considerably? Factors affecting the diagnosis and the incidence of this complication,” Journal of the Pancreas, vol. 3, no. 6, pp. 195–201, 2002. View at Google Scholar
  13. E. L. Bradley III, “A clinically based classification system for acute pancreatitis: summary of the International Symposium on Acute Pancreatitis, Atlanta, Ga, September 11 through 13, 1992,” Archives of Surgery, vol. 128, no. 5, pp. 586–590, 1993. View at Google Scholar
  14. E. Masci, G. Toti, and A. Mariani, “Complications of diagnostic and therapeutic ERCP: a prospective multicenter study,” The American Journal of Gastroenterology, vol. 96, no. 2, pp. 417–423, 2001. View at Google Scholar
  15. C.-L. Cheng, S. Sherman, J. L. Watkins et al., “Risk factors for post-ERCP pancreatitis: a prospective multicenter study,” The American Journal of Gastroenterology, vol. 101, no. 1, pp. 139–147, 2006. View at Publisher · View at Google Scholar
  16. A. M. Adbel Aziz and G. A. Lehman, “Pancreatits after endoscopic retrograde cholangio-pancreatography,” World Journal of Gastroenterology, vol. 13, no. 19, pp. 2655–2668, 2007. View at Google Scholar
  17. P. A. Testoni and F. Bagnolo, “Pain at 24 hours associated with amylase levels greater than 5 times the upper normal limit as the most reliable indicator of post-ERCP pancreatitis,” Gastrointestinal Endoscopy, vol. 53, no. 1, pp. 33–39, 2001. View at Publisher · View at Google Scholar
  18. M. Kaw and S. Singh, “Serum lipase, C-reactive protein, and interleukin-6 levels in ERCP-induced pancreatitis,” Gastrointestinal Endoscopy, vol. 54, no. 4, pp. 435–440, 2001. View at Publisher · View at Google Scholar
  19. H. Messmann, W. Vogt, A. Holstege et al., “Post-ERP pancreatitis as a model for cytokine induced acute phase response in acute pancreatitis,” Gut, vol. 40, no. 1, pp. 80–85, 1997. View at Google Scholar
  20. J. Mayer, B. Rau, F. Gansauge, and H. G. Beger, “Inflammatory mediators in human acute pancreatitis: clinical and pathophysiological implications,” Gut, vol. 47, no. 4, pp. 546–552, 2000. View at Publisher · View at Google Scholar
  21. C.-C. Chen, S.-S. Wang, R.-H. Lu, F.-Y. Chang, and S.-D. Lee, “Serum interleukin 10 and interleukin 11 in patients with acute pancreatitis,” Gut, vol. 45, no. 6, pp. 895–899, 1999. View at Google Scholar
  22. J. Devière, O. Le Moine, J.-L. Van Laethem et al., “Interleukin 10 reduces the incidence of pancreatitis after therapeutic endoscopic retrograde cholangiopancreatography,” Gastroenterology, vol. 120, no. 2, pp. 498–505, 2001. View at Publisher · View at Google Scholar
  23. M. Oezcueruemez-Porsch, D. Kunz, P. D. Hardt et al., “Diagnostic relevance of interleukin pattern, acute-phase proteins, and procalcitonin in early phase of post-ERCP pancreatitis,” Digestive Diseases and Sciences, vol. 43, no. 8, pp. 1763–1769, 1998. View at Publisher · View at Google Scholar
  24. R. Pezzilli, A. M. Morselli-Labate, R. Miniero, B. Barakat, M. Fiocchi, and O. Cappelletti, “Simultaneous serum assays of lipase and interleukin-6 for early diagnosis and prognosis of acute pancreatitis,” Clinical Chemistry, vol. 45, no. 10, pp. 1762–1767, 1999. View at Google Scholar
  25. P. Chen, Y. Yuan, S. Wang, L. Zhan, and J. Xu, “Serum matrix metalloproteinase 9 as a marker for the assessment of severe acute pancreatitis,” The Tohoku Journal of Experimental Medicine, vol. 208, no. 3, pp. 261–266, 2006. View at Publisher · View at Google Scholar